Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05687240 · ClinicalTrials.gov registry record · NA

Heart Focused Movement Effects on Cardiometabolic Risk

A NA study of Cardiometabolic Risk Factors, sponsored by Arizona State University.

Completed
Registry status
NA
Development phase
22
Enrollment target
1
Study location

NCT05687240 is a NA study of Cardiometabolic Risk Factors that has completed, run by Arizona State University. The registered enrollment target is 22 participants, below the 193-participant average among 4 other Cardiometabolic Risk Factors trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05687240, a NA study of Cardiometabolic Risk Factors, has completed, sponsored by Arizona State University.

COMPLETED
Registry status
NA
Development phase
22 participants
Enrollment target
1
Study location

Study Summary

This study is designed as a two-group parallel randomized controlled trial (N=50) to test effects of 8-weeks of Qigong/Tai Chi (QTC) intervention compared to QTC plus HRVB on HRV parameters (primary), and cardiometabolic risk factors and sequelae (secondary) (e.g., BMI, waist circumference/percent body fat, sleep quality, stress, anxiety/depression, emotional regulation, eating behaviors, and cognitive performance).

Interventions

  • BEHAVIORAL Heart rate variability biofeedback
  • BEHAVIORAL Qigong/Tai Chi

Study Locations (1)

Arizona

  • Arizona State University - Phoenix

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2020-12-01
Est. Completion 2023-07-31
Phase NA

Sponsor

Arizona State University

187 total trials

What the Registry Record Tells You About NCT05687240

The ClinicalTrials.gov registry entry for NCT05687240 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 193-participant average among 4 other Cardiometabolic Risk Factors trials with a reported enrollment target (89% lower). The listed sponsor is Arizona State University, which has 187 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cardiometabolic Risk Factors appearing as the primary indexed condition, and to 2 interventions - of which Heart rate variability biofeedback is the first listed.

NCT05687240 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.

Frequently Asked Questions

What is clinical trial NCT05687240 about?

NCT05687240 is a clinical study titled "Heart Focused Movement Effects on Cardiometabolic Risk". This study is designed as a two-group parallel randomized controlled trial (N=50) to test effects of 8-weeks of Qigong/Tai Chi (QTC) intervention compared to QTC plus HRVB on HRV parameters (primary), and cardiometabolic risk factors and sequelae (secondary) (e.g., BMI, waist circumference/percent b...

What is the current status of trial NCT05687240?

This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2020-12-01. Estimated completion is 2023-07-31.

What conditions does trial NCT05687240 study?

This clinical trial studies the following conditions: Cardiometabolic Risk Factors.

What interventions are being tested in trial NCT05687240?

The interventions under investigation include: Heart rate variability biofeedback (BEHAVIORAL), Qigong/Tai Chi (BEHAVIORAL).

Who is sponsoring clinical trial NCT05687240?

This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05687240 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiometabolic Risk Factors

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.